3-Pyrrolidin-1-ylmethyl-benzylamine, 97.0%, 250mg

Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-galactopyranoside, 95.0%, 1g

6-Bromo-2-methylbenzo[d]oxazole, 95.0%, 25g

1-BROMO-5-METHOXY-4-METHYL-2-NITROBENZENE, 95.0%, 5g

3-Chloro-5-nitropyridin-4-ol, 95.0%, 10g

(S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-5-hydroxypentanoate, 98%, 500mg

4-(4-Methylpiperazin-1-yl)phenylboronic acid pinacol ester, 96.0%, 25g

1-(4-(2-MORPHOLINOETHYL)PHENYL)GUANIDINE HCL, 95.0%, 250mg

1-Benzyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

1-(5-Bromothiophen-2-yl)-2,2,2-trifluoroethan-1-ol, 98%, 5g

ETHYL 5-CHLOROPYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLATE, 97.0%, 100mg

methyl 3-pyrrolidinylacetate hydrochloride, 95.0%, 5g

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 3.00 µm, 1 Piece(s)